drug
nepafenac
Marketedupdated 3mo agoby $HROW HARROW, INC.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 31, 2027
163 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Mar 31, 2032formulationUS 8921337
- Dec 1, 2030formulationUS 96623984.3y
- Jan 31, 2027method-of-use (U-1095)US 7834059163d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that